Hai-jian L. Sun
State Key Laboratory Of Natural Medicines
Nanjing, China
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 108 publications
PGK1 Drives Cardiac Hypertrophy by Regulating the Vimentin/PI3K/Akt Pathway.
Journal: Circulation research
Published: February 24, 2026
The Role and Mechanism of Gut Microbiota and Metabolites in Vascular Calcification.
Journal: International journal of molecular sciences
Published: December 27, 2025
Role of Hydrogen Sulfide Regulation of Programmed Cell Death: Implications for Cardiovascular Diseases.
Journal: Antioxidants & redox signaling
Published: October 25, 2025
HMC ameliorates myocardial ischaemia-reperfusion injury through suppressing cuproptosis via the de-ubiquitination and stabilization of ATP7A.
Journal: British journal of pharmacology
Published: March 31, 2025
Phillygenin ameliorates myocardial ischemia-reperfusion injury by inhibiting cuproptosis via the autophagy-lysosome degradation of CTR1.
Journal: Free radical biology & medicine
Published: March 13, 2025
USP48 protects against myocardial ischemia-reperfusion injury by stabilizing and upregulating CNN1 in type 1 diabetes mice.
Journal: Metabolism: clinical and experimental
Published: January 30, 2025
Advances in roles of Parabacteroides distasonis and its regulation by traditional Chinese medicines
Journal: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
Published: December 19, 2024
NaHS@Cy5@MS@SP nanoparticles improve rheumatoid arthritis by inactivating the Hedgehog signaling pathway through sustained and targeted release of H2S into the synovium.
Journal: Journal of nanobiotechnology
Published: November 28, 2024
Atg7 in CD4+ T cells improves intestinal mucosal inflammation by regulating Ets1-mediated T cell differentiation.
Journal: Clinical and translational medicine
Published: November 01, 2024
Hydrogen sulfide as a new therapeutic target of pulmonary hypertension: an overview with update on immunomodulation.
Journal: Frontiers in pharmacology
Published: October 25, 2024
Inhibition of PGK1 ameliorates acute kidney injury through inactivating the PKM2/ALOX12/ferroptosis pathway in a study with male mice.
Journal: Nature communications
Published: October 10, 2024
Last Updated: 09/26/2026